TLR2 and Parkinson disease: Similarly, in Parkinson’s disease, the accumulation of α-synuclein aggregates triggers microglia via TLR2 signaling, amplifying inflammatory responses, while dysfunction in gut–brain axis interactions suggests systemic contributions to CNS pathology [161].